APPLICATION SITE RASH side effect
What is APPLICATION SITE RASH ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
APPLICATION SITE RASH and Recently Reported Side Effects
APPLICATION SITE RASH and 15 most Active Side Effect polls
APPLICATION SITE RASH and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with APPLICATION SITE RASH
ABREVA ALTABAX BENGAY CATAPRES CHLORAPREP CLIMARA COMMIT DAYTRANA DURAGESIC DURAPREP EFUDEX EMSAM EXELON FENTANYL FINACEA IONSYS LEVULAN LIDODERM LOCOID MENOSTAR NEOSPORIN NEUPRO NICABATE NICORETTE NICOTINE PROGRAF SEROQUEL VOLTARENChloraprep Side Effects Report #5648708-4
Consumer or non-health professional from UNITED STATES reported CHLORAPREP problem on Mar 03, 2008. Female patient, 55 years of age, weighting 14.00 lb, was diagnosed with surgery and was treated with CHLORAPREP. After drug was administered, patient experienced the following problems/side effects: application site rash, post procedural complication, . CHLORAPREP dosage: unknown. Patient recovered.
Climara Side Effects Report #5652440-0
CLIMARA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 04, 2008. Female patient, 52 years of age, was diagnosed with skin reaction, blood cholesterol increased and was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site rash, . CLIMARA dosage: unknown. During the same period patient was treated with DOXYCYCLIN, PROMETRIUM. Patient recovered.
Duragesic Side Effects Report #5652490-4
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on Feb 25, 2008. Male patient, weighting 155.0 lb, was diagnosed with pain, restless legs syndrome, crohn's disease and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site rash, hyperhidrosis, irritability, skin infection, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, NEURONTIN, IMURAN. Patient recovered.
Neupro Side Effects Report #5664339-4
NEUPRO problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 25, 2008. Female patient, 71 years of age, was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site rash, erythema, . NEUPRO dosage: 2MG/24H,1 IN 2 D,TRANSDERMAL; 4MG/24H,1 IN 1 D,TRANSDERMAL; 6MG/24H,1 IN 1 D,TRANSDERMAL. During the same period patient was treated with BENADRYL. Patient recovered.
Fentanyl Side Effects Report #5674585-1
Consumer or non-health professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Mar 10, 2008. Female patient, weighting 136.0 lb, was diagnosed with pain, pain in extremity, muscle spasms and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site rash, back pain, gallbladder operation, hypertension, treatment noncompliance, withdrawal syndrome, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, LORTAB, LYRICA. Patient was hospitalized. Patient recovered.
Duragesic Side Effects Report #5675097-1
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 11, 2008. Female patient, weighting 250.0 lb, was diagnosed with pain in extremity, cardiac disorder, blood cholesterol increased and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site rash, chills, coma, joint swelling, treatment noncompliance, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, MORPHINE, INDERAL, SIMVASTATIN, VICODIN. Patient recovered.
Duragesic Side Effects Report #5675589-5
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on Mar 13, 2008. Female patient, weighting 117.0 lb, was diagnosed with pain, arthritis, diabetes mellitus and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site rash, restless legs syndrome, . DURAGESIC dosage: unknown. During the same period patient was treated with ENBREL, METHOTREXATE, GLUCOPHAGE. Patient recovered.
Neupro Side Effects Report #5679691-3
NEUPRO problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 11, 2008. Female patient was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site rash, . NEUPRO dosage: 6MG/24H, 1 IN 1 D, TRANSDERMAL. Patient recovered.
Neupro Side Effects Report #5679692-5
Consumer or non-health professional from UNITED STATES reported NEUPRO problem on Mar 11, 2008. Female patient was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site rash, . NEUPRO dosage: 6MG/24H, 1 IN 1 D, TRANSDERMAL. Patient recovered.
Neupro Side Effects Report #5679696-2
NEUPRO problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 11, 2008. Female patient was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site rash, . NEUPRO dosage: 6MG/24H, 1 IN 1 D, TRANSDERMAL. Patient recovered.
Neupro Side Effects Report #5679699-8
Consumer or non-health professional from UNITED STATES reported NEUPRO problem on Mar 11, 2008. Female patient was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site rash, . NEUPRO dosage: 6MG/24H, 1 IN 1 D, TRANSDERMAL. Patient recovered.
Neupro Side Effects Report #5679706-2
NEUPRO problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 11, 2008. Female patient was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site rash, . NEUPRO dosage: 6MG/24H, 1 IN 1 D, TRANSDERMAL. Patient recovered.
Climara Side Effects Report #5687561-X
Consumer or non-health professional from UNITED STATES reported CLIMARA problem on Feb 25, 2008. Female patient, 61 years of age, weighting 136.7 lb, was diagnosed with menopausal symptoms and was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site rash, . CLIMARA dosage: unknown. Patient recovered.
Bengay Side Effects Report #5625470-2
BENGAY ULTRA STRENGTH PATCH problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 04, 2008. Male patient, 35 years of age, was diagnosed with musculoskeletal pain and was treated with BENGAY ULTRA STRENGTH PATCH. After drug was administered, patient experienced the following problems/side effects: application site rash, dry skin, thermal burn, . BENGAY ULTRA STRENGTH PATCH dosage: unknown. During the same period patient was treated with ZOCOR. Patient recovered.
Climara Side Effects Report #5627710-2
Physician from UNITED STATES reported CLIMARA problem on Feb 14, 2008. Female patient was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site rash, . CLIMARA dosage: 0.6MG. Patient recovered.
Duragesic Side Effects Report #5627899-5
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 05, 2008. Female patient, weighting 168.0 lb, was diagnosed with spinal disorder, depression, pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site rash, spinal disorder, spinal operation, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, PROZAC, CLONAZEPAM, VICODIN ES, LYRICA, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
Finacea Side Effects Report #5632276-7
Consumer or non-health professional from UNITED STATES reported FINACEA problem on Dec 04, 2007. Female patient, 48 years of age, weighting 114.6 lb, was diagnosed with rosacea, anxiety and was treated with FINACEA. After drug was administered, patient experienced the following problems/side effects: application site rash, rosacea, . FINACEA dosage: unknown. During the same period patient was treated with XANAX. Patient recovered.
Nicorette Side Effects Report #5641336-6
NICORETTE problem was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2007. Female patient, 47 years of age, was treated with NICORETTE. After drug was administered, patient experienced the following problems/side effects: application site rash, malaise, . NICORETTE dosage: unknown. During the same period patient was treated with NICODERM CQ, PROZAC. Patient recovered.
Fentanyl Side Effects Report #5643289-3
Consumer or non-health professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Feb 19, 2008. Female patient, weighting 275.0 lb, was diagnosed with neuropathy peripheral and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site rash, overdose, somnolence, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. Patient died on 02/06/2008.
Fentanyl Side Effects Report #5584021-1
FENTANYL TRANSDERMAL SYSTEM problem was reported by a Pharmacist from UNITED STATES on Jan 04, 2008. Female patient was diagnosed with pain and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site rash, inadequate analgesia, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. Patient recovered.
Catapres Side Effects Report #5587454-2
Consumer or non-health professional from UNITED STATES reported CATAPRES problem on Dec 19, 2007. Male patient, 45 years of age, was diagnosed with hypertension, hypersensitivity and was treated with CATAPRES. After drug was administered, patient experienced the following problems/side effects: application site rash, . CATAPRES dosage: unknown. During the same period patient was treated with FLONASE, HYDROCHLOROTHIAZIDE. Patient recovered.
Fentanyl Side Effects Report #5599852-1
FENTANYL problem was reported by a Health Professional from UNITED STATES on Jan 17, 2008. Female patient, 46 years of age, weighting 140.0 lb, was diagnosed with pain and was treated with FENTANYL. After drug was administered, patient experienced the following problems/side effects: application site rash, dermatitis contact, . FENTANYL dosage: unknown. Patient recovered.
Climara Side Effects Report #5603910-2
Consumer or non-health professional from UNITED STATES reported CLIMARA PRO problem on Dec 27, 2007. Female patient, 56 years of age, weighting 167.6 lb, was diagnosed with menopausal symptoms and was treated with CLIMARA PRO. After drug was administered, patient experienced the following problems/side effects: application site rash, . CLIMARA PRO dosage: unknown. Patient recovered.
Chloraprep Side Effects Report #5606060-4
CHLORAPREP problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 23, 2008. Female patient, 46 years of age, weighting 185.0 lb, was diagnosed with preoperative care and was treated with CHLORAPREP. After drug was administered, patient experienced the following problems/side effects: application site rash, feeling abnormal, skin erosion, wound secretion, . CHLORAPREP dosage: unknown. Patient was hospitalized. Patient recovered.
Duragesic Side Effects Report #5608924-4
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on Jan 21, 2008. Male patient, weighting 155.0 lb, was diagnosed with pain, restless legs syndrome, crohn's disease and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site rash, hyperhidrosis, irritability, skin infection, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, NEURONTIN, IMURAN. Patient recovered.
Climara Side Effects Report #5609861-1
CLIMARA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 14, 2008. Female patient, 44 years of age, weighting 185.2 lb, was diagnosed with multiple sclerosis and was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site rash, . CLIMARA dosage: unknown. During the same period patient was treated with AVELOX. Patient recovered.
Climara Side Effects Report #5610121-3
Consumer or non-health professional from UNITED STATES reported CLIMARA problem on Jan 08, 2008. Female patient, 57 years of age, weighting 130.1 lb, was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site rash, . CLIMARA dosage: unknown. During the same period patient was treated with SYNTHROID. Patient recovered.
Neupro Side Effects Report #5610369-8
NEUPRO problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 06, 2008. Female patient, 54 years of age, weighting 242.5 lb, was diagnosed with restless legs syndrome and was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site rash, disorientation, dizziness, fear, feeling cold, heart rate increased, nausea, pruritus, . NEUPRO dosage: 2MG/24H, 1 IN 1 D, TRANSDERMAL. During the same period patient was treated with EFFEXOR, LEXAPRO, SYNTHROID, BONE SUPPLEMENT, TYLENOL EXTRA STRENGTH, VITAMIN C SUPPLEMENT, VALIUM. Patient recovered.
Duraprep Side Effects Report #5613826-3
Consumer or non-health professional from UNITED STATES reported DURAPREP problem on Oct 01, 2007. Female patient was diagnosed with preoperative care and was treated with DURAPREP. After drug was administered, patient experienced the following problems/side effects: application site rash, procedural pain, . DURAPREP dosage: unknown. Patient recovered.
Emsam Side Effects Report #5546066-7
EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 19, 2007. Female patient, 46 years of age, weighting 134.5 lb, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site rash, . EMSAM dosage: unknown. Patient recovered.
Emsam Side Effects Report #5546078-3
Consumer or non-health professional from UNITED STATES reported EMSAM problem on Sept 25, 2007. Male patient, 54 years of age, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site rash, . EMSAM dosage: unknown. Patient recovered.
Emsam Side Effects Report #5546102-8
EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2007. Female patient, 48 years of age, weighting 114.6 lb, was diagnosed with depression, panic attack and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site rash, skin discolouration, . EMSAM dosage: unknown. During the same period patient was treated with ALPRAZOLAM. Patient recovered.
Emsam Side Effects Report #5546111-9
Consumer or non-health professional from UNITED STATES reported EMSAM problem on Oct 23, 2007. Male patient, 54 years of age, weighting 169.8 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site rash, . EMSAM dosage: unknown. During the same period patient was treated with KLONOPIN. Patient recovered.
Neupro Side Effects Report #5588422-7
NEUPRO problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 16, 2007. Female patient, 65 years of age, weighting 130.1 lb, was diagnosed with parkinson's disease and was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site rash, somnolence, . NEUPRO dosage: 2MG/24H,1 IN 1 D,TRANSDERMAL ; 8MG/24H,1 IN 1 D,TRANSDERMAL. During the same period patient was treated with REQUIP, FEMHRT. Patient recovered.
Fentanyl Side Effects Report #5521050-8
Physician from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Nov 08, 2007. Female patient, weighting 228.0 lb, was diagnosed with pain, anxiety and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site rash, blood pressure fluctuation, blood test abnormal, memory impairment, onychomycosis, pain, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with TOPAMAX, ELAVIL, ADDERALL, LORAZEPAM, CYMBALTA, FLUOXETINE, SYNTHROID. Patient recovered.
Climara Side Effects Report #5521213-1
CLIMARA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 19, 2007. Female patient, 53 years of age, was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site rash, diverticulitis, . CLIMARA dosage: .05 MG/D, CONT. During the same period patient was treated with TOPROL. Patient recovered.
Fentanyl Side Effects Report #5522249-7
Consumer or non-health professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Nov 09, 2007. Male patient, weighting 218.0 lb, was diagnosed with back pain, breakthrough pain and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site rash, arterial occlusive disease, back pain, gastric disorder, gastrooesophageal reflux disease, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, HYDROCODONE BITARTRATE. Patient was hospitalized. Patient recovered.
Fentanyl Side Effects Report #5530821-3
FENTANYL TRANSDERMAL SYSTEM problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 20, 2007. Male patient, weighting 241.0 lb, was diagnosed with back pain, blood glucose decreased and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site rash, arthritis, back pain, intervertebral disc disorder, weight decreased, withdrawal syndrome, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, FENTANYL TRANSDERMAL SYSTEM, SUGAR. Patient recovered.
Catapres Side Effects Report #5531079-1
Pharmacist from UNITED STATES reported CATAPRES problem on Nov 05, 2007. Female patient, 54 years of age, was diagnosed with hypertension and was treated with CATAPRES. After drug was administered, patient experienced the following problems/side effects: application site rash, . CATAPRES dosage: unknown. Patient recovered.
Fentanyl Side Effects Report #5480139-2
FENTANYL TRANSDERMAL SYSTEM problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2007. Female patient, weighting 161.0 lb, was diagnosed with pain, anxiety and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site rash, cataract, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, VICODIN, ULTRAM. Patient recovered.
Duragesic Side Effects Report #5490571-9
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on Oct 08, 2007. Female patient was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site rash, bedridden, cataract, gastric haemorrhage, serum ferritin decreased, . DURAGESIC dosage: unknown. Patient was hospitalized. Patient recovered.
Duragesic Side Effects Report #5490576-8
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2007. Female patient, weighting 220.0 lb, was diagnosed with rheumatoid arthritis and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site rash, application site vesicles, oedema peripheral, thrombosis, . DURAGESIC dosage: unknown. Patient was hospitalized. Patient recovered.
Emsam Side Effects Report #5448779-4
Consumer or non-health professional from UNITED STATES reported EMSAM problem on June 05, 2007. Male patient, weighting 160.9 lb, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site rash, . EMSAM dosage: unknown. Patient recovered.
Emsam Side Effects Report #5448800-3
EMSAM problem was reported by a Health Professional from UNITED STATES on June 19, 2007. Female patient, 51 years of age, weighting 145.5 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site rash, . EMSAM dosage: unknown. During the same period patient was treated with ATENOLOL, HYDROCHLOROTHIAZIDE, PROMETRIUM, ALBUTEROL, ACYCLOVIR, ESTROGENIC SUBSTANCE. Patient recovered.
Emsam Side Effects Report #5448837-4
Physician from UNITED STATES reported EMSAM problem on July 13, 2007. Male patient, 73 years of age, was diagnosed with major depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site rash, . EMSAM dosage: unknown. During the same period patient was treated with KLONOPIN. Patient recovered.
Emsam Side Effects Report #5448844-1
EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2007. Female patient, 63 years of age, weighting 174.2 lb, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site rash, . EMSAM dosage: unknown. During the same period patient was treated with LISINOPRIL, PROPRANOLOL, XANAX, AMBIEN, VYTORIN. Patient recovered.
Emsam Side Effects Report #5448853-2
Physician from UNITED STATES reported EMSAM problem on Aug 07, 2007. Female patient, 74 years of age, weighting 165.3 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site rash, . EMSAM dosage: unknown. Patient recovered.
Catapres Side Effects Report #5457610-2
CATAPRES problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 06, 2007. Male patient, 83 years of age, was diagnosed with hypertension and was treated with CATAPRES. After drug was administered, patient experienced the following problems/side effects: application site rash, . CATAPRES dosage: unknown. Patient recovered.
Abreva Side Effects Report #5461238-8
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Aug 23, 2006. Female patient, 24 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site rash, oral herpes, . ABREVA dosage: unknown. Patient recovered.
Abreva Side Effects Report #5461270-4
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 31, 2006. Male patient, 35 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site rash, cheilitis, . ABREVA dosage: unknown. Patient recovered.
Abreva Side Effects Report #5462029-4
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Apr 17, 2007. Female patient, 36 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site rash, . ABREVA dosage: unknown. Patient recovered.